Physician's Choice Treatment clinical trials

A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis

This study looks at a new drug, selinexor, for people with myelofibrosis whose current treatment hasn't worked well enough. It compares selinexor to standard care chosen by doctors to see if it's safe and effective.